study reflux medication could prevent 60000 pregnancy deaths every year
Last Updated : GMT 09:07:40
Egypt Today, egypt today
Egypt Today, egypt today
Last Updated : GMT 09:07:40
Egypt Today, egypt today

Study: Reflux Medication Could Prevent 60,000 Pregnancy Deaths Every Year

Egypt Today, egypt today

Egypt Today, egypt today Study: Reflux Medication Could Prevent 60,000 Pregnancy Deaths Every Year

Reflux Medication Could Prevent 60,000 Pregnancy Deaths Every Year
Canberra - QNA

A tablet commonly used to treat reflux could prevent pre-eclampsia in pregnant women, potentially saving thousands of lives, Australian researchers have discovered. 
Pre-eclampsia is a disease that develops in pregnant women whereby toxins are released from the placenta, damaging organs and killing up to 60,000 women worldwide every year. 
It has no medical treatment and often forces expecting mothers to deliver their babies dangerously early. 
But a group of international researchers, led by a team from Melbourne's Mercy Hospital for Women at the University of Melbourne, have discovered that Nexium, a drug used to decrease the amount of acid produced in the stomach, can block the production of the toxic proteins. 
"Currently there is no option for women," Natalie Hannan, a obstretrics and gynaecology expert from the Royal Women's Hospital, told News Limited on Tuesday. 
"This is the first time we've even had the possibility of treatment on the radar and it's as simple as a tablet. 
Early lab tests have indicated that the tablet can limit the toxins which damage blood vessels and attack major organs, including the liver, kidney and brain in women with pre-eclampsia. 
"This means that women will be able to take this simple medication and make it to a later stage of pregnancy," Hannan said. 
"The benefit for the baby is that they will be able to stay inside mum for longer if we can keep her healthy. As we all know, babies delivered early can have a really tough time so that is important." The laboratory research was published Wednesday in international journal Hypertension. 
The first clinical trial of the drug will begin in South Africa with further tests planned in Australia later in 2017.

Source: QNA

 

egypttoday
egypttoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

study reflux medication could prevent 60000 pregnancy deaths every year study reflux medication could prevent 60000 pregnancy deaths every year



GMT 09:23 2019 Friday ,30 August

Testing

GMT 17:09 2017 Friday ,29 December

At least 14 dead in Mumbai fire

GMT 13:44 2017 Thursday ,21 December

Nine-time champion Loeb set for 2018 cameo

GMT 13:08 2017 Tuesday ,26 September

Bahrain's aluminum industry thriving, manned by 12,184

GMT 08:50 2017 Sunday ,03 December

Reza Zarrab, the star witness unnerving Ankara

GMT 18:26 2018 Friday ,14 December

Mashrou’ Leila headline Apple event in Dubai

GMT 12:35 2018 Thursday ,01 November

UN chief appoints new special envoy for Syria
 
 Egypt Today Facebook,egypt today facebook  Egypt Today Twitter,egypt today twitter Egypt Today Rss,egypt today rss  Egypt Today Youtube,egypt today youtube  Egypt Today Youtube,egypt today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

egypttoday egypttoday egypttoday egypttoday
egypttoday egypttoday egypttoday
egypttoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
egypttoday, Egypttoday, Egypttoday